Last updated on July 2019

A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia


Brief description of study

This is a randomized, placebo-controlled, double-blind, crossover study of oral BTD-001 in adults with Idiopathic Hypersomnia.

Detailed Study Description

This is a randomized, placebo-controlled, double-blind, crossover study of oral BTD-001 in adults with Idiopathic Hypersomnia (IH). The objectives of this study are two-fold: 1) To evaluate the efficacy of BTD-001 in subjects with IH as reflected by changes in cognitive, sleep, functional, and quality-of-life measures and 2) To characterize the safety and tolerability of oral BTD-001 administered to subjects with IH.

Clinical Study Identifier: NCT03542851

Find a site near you

Start Over

Kentucky Research Group

Louisville, KY United States
1.24miles
  Connect »